Edition:
United States

Advanced Micro Devices Inc (AMD.PH)

AMD.PH on Philadelphia Stock Exchange

13.01USD
3:14pm EDT
Change (% chg)

$-0.12 (-0.88%)
Prev Close
$13.12
Open
$13.06
Day's High
$13.11
Day's Low
$12.80
Volume
653,593
Avg. Vol
967,510
52-wk High
$15.65
52-wk Low
$6.12

Select another date:

BRIEF-Regenxbio announces completion of dosing of first cohort in Phase I clinical trial of RGX-314 gene therapy for wet AMD

* Regenxbio announces completion of dosing of first cohort in Phase I clinical trial of RGX-314 gene therapy for wet AMD

BRIEF-Advanced Micro Devices, Baidu enters into collaboration

* Advanced Micro Devices Inc - ‍AMD and Baidu announced a collaboration focused on optimizing software for amd radeon instinct gpus in baidu datacenters​ Source text for Eikon: Further company coverage:

Abu Dhabi’s Mubadala sells second stake in U.S. chipmaker AMD

ABU DHABI Abu Dhabi’s Mubadala Investment Company on Friday said it sold a 3.9 percent stake in Advanced Micro Devices in its second sale of shares in the U.S.-based semiconductor company this year.

Abu Dhabi’s Mubadala sells second stake in U.S. chipmaker AMD

ABU DHABI, Aug 4 Abu Dhabi’s Mubadala Investment Company on Friday said it sold a 3.9 percent stake in Advanced Micro Devices in its second sale of shares in the U.S.-based semiconductor company this year.

Chipmaker AMD forecasts current-quarter revenue above estimates

Advanced Micro Devices Inc forecast current-quarter revenue above analysts' estimates and raised its full-year expectations, betting on robust demand for its graphics chips and its new Ryzen processors for PCs.

UPDATE 1-Chipmaker AMD forecasts current-quarter revenue above estimates

July 25 Advanced Micro Devices Inc forecast current-quarter revenue above analysts' estimates and raised its full-year expectations, betting on robust demand for its graphics chips and its new Ryzen processors for PCs.

BRIEF-Biotime receives DSMB approval to start third patient cohort in clinical trial for dry-AMD commences patient enrollment in the U.S.

* Biotime receives DSMB approval to start third patient cohort in clinical trial for dry-AMD; commences patient enrollment in the U.S.

Chipmaker AMD's revenue rises 19 pct

July 25 Chipmaker Advanced Micro Devices Inc reported a 19 percent rise in quarterly revenue on Tuesday, boosted by demand for its graphics chips and its new Ryzen processors for PCs.

BRIEF-Mubadala Development reports 16.9 pct stake in AMD as of July 1 vs previous stake of 14.8 pct

* Mubadala Development Company reports 16.9 percent stake in Advanced Micro Devices as of July 1 versus 14.8 percent stake as of March 3 - SEC filing Source text: (http://bit.ly/2sGJWum) Further company coverage:

BRIEF-Advanced Micro Devices appoints Abhi Talwalkar to board

* AMD appoints Abhi Y. Talwalkar to board of directors Source text for Eikon: Further company coverage:

Select another date: